OFIX Orthofix Medical
Orthofix Medical earnings company data as of 7:49 PM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by OFIX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $6.8M bought by 4 insiders
- $5.7M sold by 1 insider outside a trading plan
- $2,825 sold by 1 insider under 10b5-1 plans
-
Patrick Fisher President, Global Limb ReconPlanned sale$1,416 150 shares at $9.44 0.3% of stakeTraded Oct 1 Filed Oct 5
-
Juniper Investment Company, LLC 10% owner, +2 joint filersBuy$2.7M 310,000 shares at $8.81 +9% to stakeTraded Sep 18–21 Filed Sep 23
-
Juniper Investment Company, LLC 10% owner, +2 joint filersSale$2.7M 310,000 shares at $8.81 7.6% of stakeTraded Sep 18–21 Filed Sep 22
-
Patrick Fisher President, Global Limb ReconPlanned sale$1,409 150 shares at $9.39 0.3% of stakeTraded Sep 1 Filed Sep 3
-
Juniper Investment Company, LLC 10% owner, +2 joint filersSale$403K 39,500 shares at $10.20 32% of stakeTraded Aug 14–17 Filed Aug 18
-
Juniper Investment Company, LLC 10% owner, +2 joint filersSale$2.6M 242,000 shares at $10.70 6.5% of stakeTraded May 22 Filed May 29
-
John B Henneman III DirectorBuy$61K 5,000 shares at $12.26 +5.8% to stakeTraded May 7 Filed May 8
-
Engine Capital Management, LP 10% owner, +7 joint filersBuy$2.2M 184,896 shares at $12.08 +94% to stakeTraded May 5–7 Filed May 7
-
Vickie L Capps DirectorBuy$62K 5,000 shares at $12.46 +22% to stakeTraded Mar 9–10 Filed Mar 10
-
Engine Capital Management, LP 10% owner, +7 joint filersBuy$1.7M 137,858 shares at $12.59 +59% to stakeTraded Feb 24–25 Filed Feb 26
Also filed in the last 12 months, not counted as buying or selling: 21 sales to cover taxes and 15 stock grants.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 7.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 2.02,5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.